Clinical Trial Update: Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 pilot trial investigating AMPA receptor components in the antidepressant response to ketamine for depressive and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Yale University | Conditions: Depressive Disorder, Major, Post Traumatic Stress Disorder | Phase 1 | Status: COMPLETED